UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome

Blood, 2020-12, Vol.136 (26), p.2994-3003

2020

Link zum Volltext

Verfügbarkeit prüfen

Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2010-04, Vol.54 (4), p.1603-1612

2010

Link zum Volltext

Verfügbarkeit prüfen

Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study

Intestinal research, 2020, 18(1), , pp.45-55

2020

Link zum Volltext

Verfügbarkeit prüfen

S1072 Hepatic Impact of Etrasimod for Treatment of Moderately to Severely Active Ulcerative Colitis: An Integrated Safety Summary From the Etrasimod Ulcerative Colitis Clinical Program

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S816-S817

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn’s Disease: The OPERA II Study

Inflammatory bowel diseases, 2022-07, Vol.28 (7), p.1034-1044

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease

Journal of Crohn's and colitis, 2024-05, Vol.18 (5), p.708-719

2024

Link zum Volltext

Verfügbarkeit prüfen

Normal intrathecal leukocyte cell number and composition do not decrease the incidence of post–lumbar puncture headache

Journal of neuroimmunology, 2017-09, Vol.310, p.69-71

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II

Journal of Crohn's and colitis, 2021-06, Vol.15 (6), p.938-949

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy Biomarkers

Journal of Crohn's and colitis, 2019-05, Vol.13 (6), p.702-713

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Safety, Efficacy and Pharmacokinetics of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) Monoclonal Antibody SHP647 in Crohnʼs Disease: The OPERA II Study: 606

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S347-S348

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) Antibody SHP647 in Ulcerative Colitis: An Open-Label Extension Study (TURANDOT II): 605

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S347-S347

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study

Journal of Crohn's and colitis, 2018-01, Vol.12 (2), p.188-196

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival from out-of-hospital cardiac arrest after chest compression-only CPR

JAMA : the journal of the American Medical Association, 2011-01, Vol.305 (2), p.147

Koster, Rudolph W

2011

Link zum Volltext

Verfügbarkeit prüfen

825 Anti-MAdCAM-1 Antibody (PF-00547659) for Active Refractory Crohn's Disease: Results of the OPERA Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-162-S-162

2015

Link zum Volltext

Verfügbarkeit prüfen

867 Anti-MAdCAM Monoclonal Antibody PF-00547659 Does Not Affect Immune Surveillance in the Central Nervous System of Crohn's Disease Patients Who Are Anti-TNF Inadequate Responders: Results From the Tosca Study

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-150-S-150

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-05, Vol.321 (20), p.1993

2019

Link zum Volltext

Verfügbarkeit prüfen

Respiratory Syncytial Virus Infection in Elderly Adults

The New England journal of medicine, 2005-07, Vol.353 (4), p.422-423

Gorelick, Kenneth J

2005

Link zum Volltext

Verfügbarkeit prüfen

First-in-human (FIH) trial evaluating immune activation and safety of PIN- 2 administered intravenously to patients with advanced solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2600-2600

2019

Link zum Volltext

Verfügbarkeit prüfen

Sa1764 PERCEPTION OF REMISSION AND PREFERENCE FOR DISEASE SYMPTOMS IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM A DISCRETE CHOICE EXPERIMENT

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-414-S-414

2020

Link zum Volltext

Verfügbarkeit prüfen

Sa1765 PERCEPTION OF REMISSION AND PREFERENCE FOR DISEASE SYMPTOMS IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM A DISCRETE CHOICE EXPERIMENT

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-414-S-414

2020

Link zum Volltext

Verfügbarkeit prüfen

Su2010 - The Anti-Madcam Antibody Shp647 in Crohn's Disease: Endoscopic Effects of Induction Therapy

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-665-S-665

2018

Link zum Volltext

Verfügbarkeit prüfen

Sa1774 - Incidence of Venous Thromboembolic Complications in Controlled Trials of Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-390-S-390

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(77)

Sprache

Englisch
(77)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(35)
Female
(24)
Male
(20)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Adult
(13)
Middle Aged
(12)
Adolescent
(11)
General & Internal Medicine
(11)
Aged
(10)
Medicine, General & Internal
(9)
Treatment Outcome
(8)
Double-Blind Method
(7)
Gastroenterology & Hepatology
(7)
Inflammatory Bowel Disease
(6)
Psychiatry
(6)
Young Adult
(6)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome

Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation

Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study

S1072 Hepatic Impact of Etrasimod for Treatment of Moderately to Severely Active Ulcerative Colitis: An Integrated Safety Summary From the Etrasimod Ulcerative Colitis Clinical Program

Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn’s Disease: The OPERA II Study

Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease

Normal intrathecal leukocyte cell number and composition do not decrease the incidence of post–lumbar puncture headache

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II

Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy Biomarkers

Long-Term Safety, Efficacy and Pharmacokinetics of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) Monoclonal Antibody SHP647 in Crohnʼs Disease: The OPERA II Study: 606

Long-Term Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) Antibody SHP647 in Ulcerative Colitis: An Open-Label Extension Study (TURANDOT II): 605

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study

Survival from out-of-hospital cardiac arrest after chest compression-only CPR

825 Anti-MAdCAM-1 Antibody (PF-00547659) for Active Refractory Crohn's Disease: Results of the OPERA Study

867 Anti-MAdCAM Monoclonal Antibody PF-00547659 Does Not Affect Immune Surveillance in the Central Nervous System of Crohn's Disease Patients Who Are Anti-TNF Inadequate Responders: Results From the Tosca Study

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial

Respiratory Syncytial Virus Infection in Elderly Adults

First-in-human (FIH) trial evaluating immune activation and safety of PIN- 2 administered intravenously to patients with advanced solid tumors

Sa1764 PERCEPTION OF REMISSION AND PREFERENCE FOR DISEASE SYMPTOMS IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM A DISCRETE CHOICE EXPERIMENT

Sa1765 PERCEPTION OF REMISSION AND PREFERENCE FOR DISEASE SYMPTOMS IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM A DISCRETE CHOICE EXPERIMENT

Su2010 - The Anti-Madcam Antibody Shp647 in Crohn's Disease: Endoscopic Effects of Induction Therapy

Sa1774 - Incidence of Venous Thromboembolic Complications in Controlled Trials of Inflammatory Bowel Disease

Suchergebnisse filtern